Pages that link to "Q42936596"
Jump to navigation
Jump to search
The following pages link to Antibodies to normal human melanocytes in vitiligo (Q42936596):
Displaying 50 items.
- Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo (Q24794301) (← links)
- Jean-Claude Bystryn 1938-2010. An obituary (Q30399726) (← links)
- The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I. (Q30681365) (← links)
- The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo (Q30829628) (← links)
- Autoantigens in vitiligo identified by the serological selection of a phage-displayed melanocyte cDNA expression library. (Q33479966) (← links)
- Management of vitiligo (Q34135395) (← links)
- Autoimmune melanocyte destruction in vitiligo (Q34335855) (← links)
- Serial studies of autologous antibody reactivity to melanoma. Relationship to clinical course and circulating immune complexes (Q34550480) (← links)
- GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1. (Q34692289) (← links)
- Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4( ) T lymphocytes. (Q35064131) (← links)
- GILT Modulates CD4 T-Cell Tolerance to the Melanocyte Differentiation Antigen Tyrosinase-Related Protein 1 (Q35552274) (← links)
- Mammalian tyrosinase-related protein-1 is recognized by autoantibodies from vitiliginous Smyth chickens. An avian model for human vitiligo (Q35798261) (← links)
- Ocular pathology in melanomatous Sinclair miniature swine (Q35818436) (← links)
- Autoantibodies as diagnostic and predictive markers of vitiligo. (Q35934690) (← links)
- Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein (Q36365511) (← links)
- Self Antigens Expressed by Solid Tumors Do Not Efficiently Stimulate Naive or Activated T Cells: Implications for Immunotherapy (Q36380506) (← links)
- Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo (Q36389114) (← links)
- Update on the genetics characterization of vitiligo. (Q36465456) (← links)
- Vitiligo: auto-immunity and immune responses (Q36478782) (← links)
- NALP inflammasomes: a central role in innate immunity. (Q36912187) (← links)
- Harnessing autoimmunity (vitiligo) to treat melanoma: a myth or reality? (Q36958358) (← links)
- Altered expression of four miRNA (miR-1238-3p, miR-202-3p, miR-630 and miR-766-3p) and their potential targets in peripheral blood from vitiligo patients. (Q38433669) (← links)
- Alopecia totalis and vitiligo in common variable immunodeficiency (Q38651121) (← links)
- Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo (Q38943432) (← links)
- Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8. (Q39331724) (← links)
- Immunology and immunotherapy of human malignant melanoma. (Q39477930) (← links)
- Organ-specific autoimmunity: a 1986 overview (Q39506816) (← links)
- Vitiligo and the Vogt-Koyanagi-Harada syndrome. (Q39644944) (← links)
- Patients affected by vitiligo and autoimmune diseases do not show antibodies interfering with the activity of the melanocortin 1 receptor (Q39723783) (← links)
- Nonmelanoma skin cancer, melanomas, warts, and viral oncogenesis. (Q40193202) (← links)
- Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients (Q40282263) (← links)
- Melanocyte destruction and repopulation in vitiligo (Q40591940) (← links)
- Review of the etiopathomechanism of vitiligo: a convergence theory (Q40742658) (← links)
- Vitiligo: where do we stand? (Q40820967) (← links)
- Recognition of autoantigens by patients with melanoma (Q40844530) (← links)
- High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo (Q41007804) (← links)
- Relation Between the Incidence and Level of Pigment Cell Antibodies and Disease Activity in Vitiligo (Q41144130) (← links)
- Liver cell surface expression of the antigen reacting with liver-kidney microsomal antibody (LKM). (Q41592867) (← links)
- Immune mechanisms in vitiligo (Q41665546) (← links)
- Complementary expression of melanosomal antigens and constant expression of pigment-independent antigen during the evolution of melanocytic tumours (Q41754906) (← links)
- Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV). The new American Joint Committee on Cancer (Q41932115) (← links)
- Genetic variations in NALP1 MRNA expressions in human vitiligo (Q42110711) (← links)
- Ocular pathology in the minimally depigmented subline of the vitiliginous Smyth chicken (Q42513433) (← links)
- Morphology of melanocytes in hair bulbs and eyes of vitiligo mice (Q42738212) (← links)
- Treatment of vitiligo vulgaris with the combination therapy of topical steroid and vitamin D3 compound (Q42966362) (← links)
- Vitiligo: peripheral T-cell subset imbalance as defined by monoclonal antibodies (Q43916658) (← links)
- Depletion and repopulation of Langerhans cells in nonsegmental type vitiligo (Q44113239) (← links)
- Autoantibodies in vitiligo patients are not directed to the melanocyte differentiation antigen MelanA/MART1. (Q44116002) (← links)
- Vitiligo: the historical curse of depigmentation (Q47286652) (← links)
- Vitiligo. Therapeutic advances (Q47614455) (← links)